TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04080466

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: PET-MRI
Description: Positron emission tomography combined with magnetic resonance imaging (PET-MRI) is a technology that allows physicians to examine bone and cartilage at the molecular level.~Participants in the Cam Group will undergo the scan twice; once before surgery and once 2-years post-operative. Participants in the Control Group will undergo the scan once as part of the study.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Motion Analysis
Description: Motion analysis is the study of how joints move and which muscles fire during specific movements. In the lab, participants will be asked to perform movements that they might do during a typical day or when exercising.~Participants in the Cam Group will undergo the Motion Analysis session twice; once before surgery and once 2-years post-operative. Participants in the Control Group will undergo the Motion Analysis session once as part of the study.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Motion Analysis
Description: Motion analysis is the study of how joints move and which muscles fire during specific movements. In the lab, participants will be asked to perform movements that they might do during a typical day or when exercising.~Participants in the Cam Group will undergo the Motion Analysis session twice; once before surgery and once 2-years post-operative. Participants in the Control Group will undergo the Motion Analysis session once as part of the study.

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 3T MRI
Description: Participants will undergo a 3-Tesla (3T) Magnetic Resonance Imaging (MRI) of both hips.~Participants in the Cam Group will undergo this scan once as part of their standard of care. Participants in the Control Group will undergo this scan once as part of the study.

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: 3T MRI
Description: Participants will undergo a 3-Tesla (3T) Magnetic Resonance Imaging (MRI) of both hips.~Participants in the Cam Group will undergo this scan once as part of their standard of care. Participants in the Control Group will undergo this scan once as part of the study.
Study: NCT06345807

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Individuals activity programs
Description: activity program will be adjusted every week by practitioner for each patient following data coming from the wearable device ( connected whatch and bellt for 12 months)

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: activity program
Description: pre established program without adjustement. The patient has connected whatch and bellt for 12 months

Intervention type: OTHER
Group type: OTHER
Intervention: no Physical Activity program
Description: no Physical Activity (PA)program but just PA recommendations.PA is carried out independently (common practice).The patient has connected whatch and bellt for 12 months
Study: NCT06042244

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multimodal Exercise Group
Description: Listed in arm/ group descriptions

Intervention type: OTHER
Group type: OTHER
Intervention: Waitlist
Description: listed in arm/group description
Study: NCT05637086

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Phenytoin
Description: Phenytoin remains a highly effective anti-epileptic drug, especially in generalized seizure management. Unfortunately, phenytoin efficacy on epileptic seizure is apparently reduced with its chronic use

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Phenytoin
Description: Phenytoin remains a highly effective anti-epileptic drug, especially in generalized seizure management. Unfortunately, phenytoin efficacy on epileptic seizure is apparently reduced with its chronic use

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Phenytoin
Description: Phenytoin remains a highly effective anti-epileptic drug, especially in generalized seizure management. Unfortunately, phenytoin efficacy on epileptic seizure is apparently reduced with its chronic use
Study: NCT04525196

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical activity.
Description: The procedure under study (physical activity program) will include, each week for 12 months, two sessions dedicated to the development of aerobic capacity and a muscle building session.~The experimental group will therefore be offered 3 sessions of Physical Activity (PA) per week. The PA will be positioned in the first two hours after the start of the dialysis session. Each session will include 5 minutes of general warm-up, then 15 minutes of PA itself and finally 5 minutes of cool down period. The PA time itself will be increased as the sessions progress, according to the progress and improvement of physical capabilities of patients.
Study: NCT04906798

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-385
Description: Test Drug

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-385
Description: Test Drug

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D744
Description: Reference Drug

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D744
Description: Reference Drug
Study: NCT05637086

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pentoxifylline 400 MG
Description: Pentoxifylline (PTX) has a well validated immune modulatory and anti-inflammatory efficacy

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Celecoxib 200mg
Description: Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID) used to treat mild to moderate pain and help relieve symptoms of arthritis
Study: NCT05453552

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Granulocyte Colony-Stimulating Factor(G-CSF)
Description: G-CSF was administered at 5 ug/kg/day on days-17 to -10. When white blood cell is more than 20G/L, stop using G-CSF.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Granulocyte Colony-Stimulating Factor(G-CSF)
Description: G-CSF was administered at 5 ug/kg/day on days-17 to -10. When white blood cell is more than 20G/L, stop using G-CSF.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Decitabine (DAC)
Description: Decitabine was administered at 20mg/m2/day on days -14 to -10.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Decitabine (DAC)
Description: Decitabine was administered at 20mg/m2/day on days -14 to -10.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Busulfan
Description: Busulfan was administered at 3.2 mg/kg/day on days -7 to -4 in G-CSF+DAC+BUCY group.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine (FLU)
Description: Fludarabine was administered at 30 mg/m2/day on days -7 to -3.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cyclophosphamide (CY)
Description: Cyclophosphamide was administered at 60 mg/kg/day on days -3,-2.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Busulfan (BU)
Description: Busulfan was administered at 3.2 mg/kg/day on days -6 to -3 in G-CSF+DAC +BF group.
Study: NCT02875262

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Deferoxamine
Description: Patients will be given deferoxamine 32 mg/kg/day (max iv rate 15 mg/kg/hr), patients with ferritin levels between 2,000 and 3,000 ng/ml will receive 32 mg/kg/day and patients with serum ferritin levels below 2,000 ng/ml wil receive 25 mg/kg/day.during 3 days

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo (NaCl 0.9%) in equal dose to treatment
Study: NCT04810715

Intervention type: OTHER
Intervention: Patients with Ankylosing Spondylitis
Description: Observational study, not applicable
Study: NCT05013008

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Finerenone (Kerendia, BAY94-8862)
Description: Oral tablet; starting at 10 mg or 20 mg; once daily; received in previous interventional Phase 3 trial FIGARO-DKD; no new intervention was administered in this biomarker study.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral tablet; starting at 10 mg or 20 mg; once daily; received in previous interventional Phase 3 trial FIGARO-DKD; no new intervention was administered in this biomarker study.
Study: NCT05442047

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NNC6019-0001
Description: Participants will receive i.v infusionof NNC6019-0001.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NNC6019-0001
Description: Participants will receive i.v infusionof NNC6019-0001.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (NNC6019-0001)
Description: Participants will receive i.v. infusion of placebo (NNC6019-0001).
Study: NCT06350175

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Nicotine Replacement Therapy Agent
Description: The NRT Agents-- 21mg nicotine patches (x14) and 2 mg nicotine lozenges (\~210).

Intervention type: OTHER
Group type: OTHER
Intervention: West Virginia Quit Line
Description: Instructional Pamphlets and contact information for the WV QL. A telehealth line set up to assist people of WV to quit smoking.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: West Virginia Quit Line
Description: Instructional Pamphlets and contact information for the WV QL. A telehealth line set up to assist people of WV to quit smoking.
Study: NCT04670874

Intervention type: OTHER
Intervention: Quality-of-Life Assessment
Description: Complete quality of life questionnaire

Intervention type: OTHER
Intervention: Questionnaire Administration
Description: Complete quality of life questionnaire
Study: NCT05759663

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: MIRRAD
Description: Repair of the diastasis with MIRRAD technique

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Plication of the entire diastasis arm
Description: Plication of the entire diastasis
Study: NCT06297967

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetic Acid
Description: The intervention treatment will consist of cleaning with water and soap, application of a compress soaked in 2% dilution of glacial acetic acid (CAS 64-19-7) for 15 minutes, irrigation with distilled water, application of peri-ulcer barrier cream or spray, and the application of ActicoatⓇ on the ulcer bed. Depending on the amount of exudate, more or less alginate will be added as a secondary dressing. A tertiary dressing of polyurethane foam or bandage will be applied according to the area and the nurse's discretion.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prontosan
Description: The treatment includes ulcer cleansing with water and soap, application of ProntosanⓇ compress for 15 minutes, subsequent irrigation with distilled water, application of peri-ulcer barrier cream or spray, and the application of ActicoatⓇ on the wound bed. More or less alginate will be applied depending on the amount of exudate. A tertiary dressing of polyurethane foam or bandage will be applied according to the area and the nurse's discretion.
Study: NCT05023239

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: UG-SZM Group
Description: The patients will be receive Ultrasound-Guided Suprazygomatic Maxillary Nerve Blocks 10 mL of a local anesthetic mixture composed of 0.25% plain bupivacaine .

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: UG-SZM Group
Description: The patients will be receive Ultrasound-Guided Suprazygomatic Maxillary Nerve Blocks 10 mL of a local anesthetic mixture composed of 0.25% plain bupivacaine .
Study: NCT06346639

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 16-day hot and cold acclimation
Description: Acclimation program will consist of 8 brief cold water immersions (CWI; 14°C 5 min) and 8 hot water immersions (HWI; 45°C 5 min). Heat and cold sessions will be performed on separate days (i.e., 1st day hot exposure, 2nd day cold exposure, 3rd day hot exposure, etc.).
Study: NCT06600997

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Flow Diversion for Endovascular Treatment of Intracranial Aneurysms
Description: Flow Diversion for Endovascular Treatment of Intracranial Aneurysms

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional endovascular therapy (stent-assisted coiling, balloon-assisted coiling, or coiling) for endovascular treatment of intracranial aneurysms
Description: Conventional endovascular therapy (stent-assisted coiling, balloon-assisted coiling, or coiling) for endovascular treatment of intracranial aneurysms
Study: NCT06606197

Intervention type: OTHER
Intervention: Having sex with other men
Description: Having sex with other men
Study: NCT06606171

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Chair Sitting (30 minutes)
Description: This intervention involves a single session of chair sitting for 30 minutes, where participants will sit in a standardized non-swivel chair and perform desk-based activities like computer use.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Floor Sitting (30 minutes)
Description: This intervention entails a single session of floor sitting for 30 minutes, with participants seated on a cushioned mat performing similar desk activities as in the chair sitting session.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Daily Floor Sitting Practice (1 month)
Description: Participants will be instructed to incorporate at least one hour of floor sitting into their daily routine for a duration of one month.
Study: NCT06601478

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The MedLIFE app
Description: The intervention arm will receive the lifestyle counselling by the MEDLIFE app, and the control arm will go on with standard lifestyle recommendations in the form of a two-page written handout.
Study: NCT05798299

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Arm 1: Transdiagnostic intervention
Description: The UP-C/C consists of 15 weekly sessions for children, each lasting 90 minutes. It is also composed by three sessions for parents and a meeting with the family prior to the exposure sessions. Parents have access to weekly psychoeducational material (in written and in video format) and help the children with homework completion.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Arm 2: Anxiety-focused intervention
Description: The Coping Cat in group format is a cognitive-behavioral evidence-based intervention for anxiety problems. It is composed by 16 90-minute sessions for children and two parenting sessions.
Study: NCT05330728

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Suggestions for lifestyle changes+ Abdominal massage
Description: Suggestions for lifestyle changes+ abdominal massage will be applied. Suggestions including regular and balanced diet, fluid consumption, regular walking and abdominal exercises and correct toilet habits will be given once. Abdominal massage will be applied 3 times a week for 4 weeks.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Suggestions for lifestyle changes+ Kinesio taping
Description: Suggestions including regular and balanced diet, fluid consumption, regular walking and abdominal exercises and correct toilet habits will be given once. Kinesio taping will be applied 3 times a week for 4 weeks.

Intervention type: OTHER
Group type: OTHER
Intervention: Suggestions for lifestyle changes
Description: Suggestions including regular and balanced diet, fluid consumption, regular walking and abdominal exercises and correct toilet habits will be given once.
Study: NCT04853069

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Transdermal estradiol gel
Description: Patients will receive standard care +/- (randomsed 1:1) transdermal 17ß-estradiol gel (3 mg; applied to forearm, upper arm and shoulder) for ten days.
Study: NCT06210828

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telerehabilitation
Description: Two weekly exercise sessions over a 12-week period at home via LINE Video call with physical therapist. Focusing on lower extremity strengthening and balance exercises. In addition to the guided sessions, participants are encouraged to perform self-directed exercises one day per week.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Receive fall prevention exercise brochure
Study: NCT05365438

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Omega 3-Atorvastatin
Description: Atmeg 2 capsules with 1 pack of Omethyl cutielet

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Omega 3-Atorvastatin
Description: Atmeg 2 capsules

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Atorvastatin-Ezetimibe
Description: ezetimibe/atorvastatin 10/20 mg
Study: NCT04633096

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: tailored feedback of depression screening results
Description: The feedback for the participant contains the screening result, information about depression in general, guideline based treatment recommendations for patients and contact-information for treatment. The information is tailored to the participant's individual symptom profile, illness perceptions and preferences.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: standardized feedback of depression screening results
Description: The feedback for the participant contains the screening result, information about depression in general, guideline based treatment recommendations for patients and contact-information for treatment.
Study: NCT05371002

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online group nonviolent communication (NVC) interventions
Description: The primary purpose of NVC as defined by Dr. Marshall Rosenberg is to resolve interpersonal conflict using empathic communication skills. Nonviolence does not refer to the mere absence of physical harm. It is a way of life that helps us to transform old patterns of defensiveness and aggressiveness into compassion and empathy and to improve the quality of all types of relationships. The basic model of NVC consists of four key principles: the separation of observation from evaluation (observation), exploring and expressing the feelings that emerge from observations (feeling), taking responsibility for one's feelings (need), and telling others the need to enrich lives (request). A book on NVC specifically targets parents to improve communication and connection with their children. The NVC model emphasizes the importance of observation and has similarities with the concept of mindful parenting, which refers to a non-judgmental and open parenting style.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Waitlist control group
Description: Waitlist control, but included a short active intervention during the 2nd and 3rd assessments.
Study: NCT05434728

Intervention type: OTHER
Intervention: 20 ml venous blood collection
Description: participant blood sample will be divided between sample EDTA sample tubes for thrombin generation testing and viscoelastic (ROTEM) testing of impaired hemostasis

Intervention type: OTHER
Intervention: 20 ml venous blood collection
Description: participant blood sample will be divided between sample EDTA sample tubes for thrombin generation testing and viscoelastic (ROTEM) testing of impaired hemostasis

Intervention type: OTHER
Intervention: 20 ml venous blood collection
Description: participant blood sample will be divided between sample EDTA sample tubes for thrombin generation testing and viscoelastic (ROTEM) testing of impaired hemostasis
Study: NCT05717413

Intervention type: DEVICE
Intervention: metatarsophalangeal joint endoprosthesis
Description: arthroplasty of 1 metatarsophalangeal joint
Study: NCT05460728

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dry needling
Description: A three-weekly session of DNT was administered with an acupuncture needle (0.30 × 50 mm; Huan Qiu, Suzhou, China). For each session, DNT was applied in the deltoid, biceps brachialis, wrist extensors and flexors, thenar muscles, vastus medialis, gastrocnemius medialis, and tibialis anterior (Hong, 1994). Following focal twitch responses (maximum three), the dry needle was left inserted for 15 minutes in each muscle.
Study: NCT06049823

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation
Description: Different grafting strategy of alveolar ridge preservation with different sealing materials

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation
Description: Different grafting strategy of alveolar ridge preservation with different sealing materials

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation
Description: Different grafting strategy of alveolar ridge preservation with different sealing materials
Study: NCT06379269

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: App healthcare
Description: Self-developed app: includes home stretching and strengthening exercises, muscle release technique instruction.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: general education and home rehab program
Study: NCT06428929

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The musical and lighted baby crib mobile:
Description: The musical and lighted baby crib mobile: It measures 43.5x33x9.5 cm and is made of plastic. It is recommended for use in infants 0-12 months. It has music that makes it easier for babies to fall asleep by reducing stress. This baby mobile has a projection and music function. In addition, the mobile has a 360° flexible swivel bracket that can be adjusted as desired. The surface of the apparatus of the mobile, which is designed to be environmentally and baby friendly, is smooth. There are four rattles on the mobile
Study: NCT05158127

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AlloRx
Description: cultured allogeneic adult umbilical cord derived mesenchymal stem cells
Study: NCT05702840

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Resistance exercise training + weight loss group
Description: Doing resistance exercises as well as following the weight watchers weight loss programme for a 12-week period

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Weight loss only group (WL)
Description: Only following the weight watchers weight loss programme for a 12-week period
Study: NCT05445999

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: High-Definition transcranial electrical stimulation
Description: According to the results of structural phase magnetic resonance and electroencephalogram, four optimal stimulation parameters will be determined.Transcranial electrical stimulation devices (Sorterix)will be used for intervention.In each cycle, the stimulation will be performed every night during weekdays,a total of 10 times.A maximum of four cycles of intervention will be performed for each patient, depending on the efficacy and the their wishes.